Login / Signup

Comparing a biosimilar follitropin alfa (Cinnal-fⓇ) with Gonal-fⓇ in women undergoing ovarian stimulation: An RCT.

Batool Hossein RashidiKhashayar SayyariRamin HeshmatSaeid AmanpourEnsieh Shahrokh TehraninejadMasoumeh MasoumiFarhang Rezaei
Published in: International journal of reproductive biomedicine (2021)
35 yr undergoing ICSI. Our findings confirm that the efficacy and safety profiles of Cinnal-fⓇ and Gonal-fⓇ are similar.
Keyphrases
  • pregnancy outcomes
  • polycystic ovary syndrome
  • replacement therapy
  • pregnant women
  • cervical cancer screening
  • adipose tissue
  • smoking cessation